Literature DB >> 22398052

Management of inflammatory bowel disease with vitamin D: beyond bone health.

Neeraj Narula1, John K Marshall.   

Abstract

A relationship between vitamin D and several disorders, including Crohn's disease (CD), has recently been proposed. Vitamin D appears to have several important actions beyond the maintenance of bone health, including various effects on the immune system. Vitamin D deficiency has been implicated in the development of CD, and its analogues may have a role in the treatment of CD. Current research also suggests a role for vitamin D in counteracting some IBD-specific complications, including osteopenia, colorectal neoplasia, and depression. There remains a need for prospective studies to further delineate these relationships. Given current evidence and the apparent safety of vitamin D supplementation, it appears reasonable to screen for and treat vitamin D deficiency in patients with IBD.
Copyright © 2011 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22398052     DOI: 10.1016/j.crohns.2011.10.015

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  23 in total

Review 1.  Vitamin D in pediatric age: consensus of the Italian Pediatric Society and the Italian Society of Preventive and Social Pediatrics, jointly with the Italian Federation of Pediatricians.

Authors:  Giuseppe Saggese; Francesco Vierucci; Flavia Prodam; Fabio Cardinale; Irene Cetin; Elena Chiappini; Gian Luigi De' Angelis; Maddalena Massari; Emanuele Miraglia Del Giudice; Michele Miraglia Del Giudice; Diego Peroni; Luigi Terracciano; Rino Agostiniani; Domenico Careddu; Daniele Giovanni Ghiglioni; Gianni Bona; Giuseppe Di Mauro; Giovanni Corsello
Journal:  Ital J Pediatr       Date:  2018-05-08       Impact factor: 2.638

2.  Vitamin D deficiency and disease outcomes in South Asian patients with IBD.

Authors:  Catriona A Boyd; Jimmy K Limdi
Journal:  Dig Dis Sci       Date:  2013-04-19       Impact factor: 3.199

3.  Serum 25-hydroxyvitamin D concentration and inflammatory bowel disease characteristics in Romania.

Authors:  Gabriela Dumitrescu; Catalina Mihai; Mihaela Dranga; Cristina Cijevschi Prelipcean
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

4.  Factors associated with vitamin D deficiency in a multicultural inflammatory bowel disease cohort.

Authors:  Sukhdev Chatu; Vivek Chhaya; Rosamund Holmes; Penny Neild; Jin-Yong Kang; Richard C Pollok; Andrew Poullis
Journal:  Frontline Gastroenterol       Date:  2012-10-31

5.  Risk Factors for Vitamin D Deficiency and Impact of Repletion in a Tertiary Care Inflammatory Bowel Disease Population.

Authors:  Samantha Zullow; Guruprasad Jambaulikar; Ankur Rustgi; Sandra Quezada; Raymond K Cross
Journal:  Dig Dis Sci       Date:  2017-05-25       Impact factor: 3.199

Review 6.  Environmental risk factors for inflammatory bowel diseases: Evidence based literature review.

Authors:  Ayokunle T Abegunde; Bashir H Muhammad; Owais Bhatti; Tauseef Ali
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742

Review 7.  Review article: vitamin D and inflammatory bowel diseases.

Authors:  V P Mouli; A N Ananthakrishnan
Journal:  Aliment Pharmacol Ther       Date:  2013-11-17       Impact factor: 8.171

8.  Environmental risk factors for inflammatory bowel disease.

Authors:  Ashwin N Ananthakrishnan
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-06

9.  Association between reduced plasma 25-hydroxy vitamin D and increased risk of cancer in patients with inflammatory bowel diseases.

Authors:  Ashwin N Ananthakrishnan; Su-Chun Cheng; Tianxi Cai; Andrew Cagan; Vivian S Gainer; Peter Szolovits; Stanley Y Shaw; Susanne Churchill; Elizabeth W Karlson; Shawn N Murphy; Isaac Kohane; Katherine P Liao
Journal:  Clin Gastroenterol Hepatol       Date:  2013-10-23       Impact factor: 11.382

10.  Normalization of plasma 25-hydroxy vitamin D is associated with reduced risk of surgery in Crohn's disease.

Authors:  Ashwin N Ananthakrishnan; Andrew Cagan; Vivian S Gainer; Tianxi Cai; Su-Chun Cheng; Guergana Savova; Pei Chen; Peter Szolovits; Zongqi Xia; Philip L De Jager; Stanley Y Shaw; Susanne Churchill; Elizabeth W Karlson; Isaac Kohane; Robert M Plenge; Shawn N Murphy; Katherine P Liao
Journal:  Inflamm Bowel Dis       Date:  2013-08       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.